RITONAVIR
Substance profile for UNII O3J8G9O825, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 392622Substance Identity#
- UNII
- O3J8G9O825
- Preferred term
- RITONAVIR
- Registry number
- 155213-67-5
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C37H48N6O5S2
Chemical And Database Identifiers#
- InChIKey
- NCDNCNXCDXHOMX-XGKFQTDJSA-N
- SMILES
- CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
- RxCUI
- 85762
- PubChem
- 392622
- NCIt
- C1609
- INN ID
- 7449
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 2 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 2 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.] | 1567 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.] | 1567 |
| ACTIVE INGREDIENT | NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] | 1509 |
| ACTIVE MOIETY | NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] | 1509 |
| ACTIVE INGREDIENT | NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.] | 1503 |
| ACTIVE MOIETY | NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.] | 1503 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1405 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1405 |
| ACTIVE MOIETY | VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.] | 203 |
| ACTIVE INGREDIENT | VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.] | 203 |
| ACTIVE INGREDIENT | TECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.] | 53 |
| ACTIVE MOIETY | TECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.] | 53 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH] | 4 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH] | 4 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 |
| ACTIVE INGREDIENT | NORVIR (RITONAVIR) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 |
| ACTIVE MOIETY | NORVIR (RITONAVIR) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 |
pubchem.ncbi.nlm.nih.gov/compound/392622
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=85762
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1609
precision.fda.gov/uniisearch/srs/unii/O3J8G9O825